الولايات المتحدة · منصات وبيانات · TipRanks

Tempus AI expands collaboration with Bristol Myers

نشره TipRanks · الولايات المتحدة منذ 16 س

Tempus AI (TEM) announced a multi-year agreement with Bristol Myers Squibb (BMY), under which BMS will license multimodal oncology data from Tempus through 2031 to ...

اقرأ المقال كاملًا على TipRanks سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.tipranks.com)

يستحق القراءة أيضًا

The Motley Fool

Not Nvidia. Not Micron. This Little-Known Chip Stock Is the AI Boom's Best-Kept Secret.

MarketBeat

Tractor Supply's Q3 Beat Plants the Seeds for a Stock Rebound

Seeking Alpha

Celestica Q3 2026 earnings preview: Analysts expect wide Y/Y growth

MarketWatch

We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?

Investing.com

Earnings call transcript: Ameris Bancorp tops Q3 2026 EPS forecast

Benzinga